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Abstract
. Objective: Tumor necrosis factor-a TNF-a is a pleiotropic cytokine binding to and thereby stimulating vascular cells. TNF-a
mediated intermediate stimulation of vascular cells is believed to play a pivotal role in the development of arteriosclerosis. While
extensive information has recently become available on gene induction by TNF-a, less is known about gene suppression by TNF-a in
vascular cells. Endothelial cells are the first cell layer within the vessel wall interacting with circulating, cytokine releasing cells.
Therefore, they were selected as target for these study. Methods: A differential screening approach has been used to isolate cDNAs
. whose abundance was suppressed by incubating bovine aortic endothelial cells BAEC for 6 h with 1 nM TNF-a. The gene expression
of 6 isolated cDNAs after TNF-a was investigated by dot blots and nuclear run-on analysis in BAEC. The investigated genes were
partially or completely sequenced. Differential expression after TNF-a stimulation of BAEC, bovine fibroblasts and vascular smooth
. muscle cells SMC was studied by Northern blots. RNA transcripts of the clone C7 in aortic aneurysms were examined by in situ
hybridization. Results: 49 independent cDNAs were isolated by the differential screening approach and 6 clones were further analyzed.
These genes were downregulated in a time and dose dependent manner in BAEC. Sequence analysis revealed that 3 cDNAs encoded
.  .  . previously unidentified genes C1, C5, C7 , while 3 encoded known genes: connective tissue growth factor CTGF; A1 , fibronectin A8
. and the mitochondrial genome B1 . A1 and B1 were suppressed in BAEC, fibroblasts and SMC, whereas A8, C1, C5 and C7 were not
uniformly downregulated in the investigated cells. C7 RNA transcripts were exclusively induced in the endothelium of an uninflamed
aortic aneurysm. The transcripts were undetectable in an inflamed aortic aneurysm and control vessels. Conclusions: Gene suppression is
a prominent feature of the intermediate effect of TNF-a on endothelial cells. Differences in the expression of the tested genes in
endothelial cells, fibroblasts and vascular smooth muscle cells open possibilities for the study of cellular interactions in the vascular wall
in disease situations with high local TNF-a concentrations. q1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
The endothelium forms the interface between circulat-
ing blood and extravascular tissues. It plays a central role
) . Corresponding author. Tel.: q49 6221 568604r568605; Fax: q49
. 6221 564101.
1 The first two authors contributed equally to the work presented.
2 Current address: Department of Surgery, Harvard Medical School,
Boston, USA.
in physiologic processes such as embryogenesis, angiogen-
esis, nutrient uptake and maintenance of vascular integrity.
The endothelium has also been implicated in diseases such
w x wx wx as arteriosclerosis 1,2 , tumor growth 3 , metastasis 4 ,
wx thrombotic and inflammatory diseases 5 .
A pleiotropic cytokine previously shown to alter the
endothelial cell phenotype is tumor necrosis factor-a
Time for primary review 23 days.
0008-6363r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved.
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. wx TNF-a 6,7 . The change of the endothelial cell pheno-
type in cytokine mediated diseases involves upregulation
wx of genes coding for leukocyte adhesion molecules 8,9 ,
wx activators of coagulation 10 , or inhibitors of fibrinolysis
wx 11 . Thus the endothelium must adapt its phenotype in
response to signals released by other cells. Genes upregu-
wx lated by TNF-a have extensively been studied 12–15 ,
while suppression of gene transcription has received less
attention. Examples of genes relevant in cardiovascular
diseases and downregulated in endothelial cells by TNF-a
wx are thrombomodulin 16 , the constitutive nitric oxide syn-
wx thase 17,18 and vascular endothelial cell growth factor
wx receptors 19 . These results show that the TNF-a medi-
ated change in the endothelial cell phenotype occurs not
only by up-, but also by downregulation of gene expres-
sion.
Induction of tissue factor, leukocyte adhesion molecules
and others occur at the transcriptional level within minutes
after TNF-a stimulation. Similar the repression of throm-
bomodulin or the constitutive nitric oxide synthase occurs
very rapidly after TNF-a stimulation. Therefore, we have
recently initiated systematic studies in cultured bovine
. aortic endothelial cells BAEC to identify genes still
downregulated by TNF-a after at least 6 h. This study was
not addressed to genes for which mRNA expression al-
ready returns to baseline values after 6 h TNF-a stimula-
tion of BAEC. We have identified 6 intermediate response
genes, 3 of these genes are known: connective tissue
.  . growth factor CTGF; A1 , fibronectin A8 and the mito-
. chondrial genome B1 . The sequences of the remaining 3
. genes C1, C5, C7 have not been reported previously. The
expression of these genes was investigated after TNF-a
stimulation of vascular cells, namely BAEC, fibroblasts
. and vascular smooth muscle cells SMC . RNA transcripts
of the new gene C7 were detected by in situ hybridization
in human aortic aneurysms in comparison to controls. Our
data provide new insights into the TNF-a mediated inter-
mediate response on endothelial cells and open possibili-
ties for the study of cellular interactions in the vascular
wall in situations where high local TNF-a concentrations
are present.
2. Methods
2.1. Cell culture
Cells were cultured in Dulbecco’s minimal essential
. medium DMEM; Gibco BRL, Eggenstein, Germany sup-
 plemented with 10% fetal calf serum FCS; Gibco BRL,
. Eggenstein, Germany , 600 mgrml glutamine, 100 Urml
penicillin, and 100 Urml streptomycin at 378C, 5% CO2
2 . in 150 cm flasks Nunc, Wiesbaden, Germany .
. Bovine aortic endothelial cells BAEC were isolated as
wx described previously 7,20 , characterized by the expres-
sion of von Willebrand factor, thrombomodulin, and mor-
phologic features. Experiments were performed with cells
between passages 5–10 that had been confluent for 2 days.
Bovine fibroblasts were prepared from foreskin and
identified by immunohistochemical staining with a mono-
 clonal antibody against fibronectin Sigma-Aldrich,
. Deisenhofen, Germany . Cells for experiments were used
. between passage 3–5. Vascular smooth muscle cells SMC
were isolated from the media of a bovine aorta as de-
wx scribed 21 and characterized by immunohistochemical
 staining with a monoclonal antibody against a-actin Pro-
. Gen, Heidelberg, Germany .
 8 Human recombinant TNF-a 1=10 Urmg; Knoll
. AG, Ludwigshafen, Germany was added in aliquots, di-
luted in DMEM containing 10% FCS, to 2 days confluent
cells. Unless not otherwise indicated, 1 nM TNF-a was
incubated for 16 h. TNF-a activity was confirmed by its
capacity of inducing tissue factor expression in BAEC and
wx in human umbilical vein endothelial cells 10 . Cyclohex-
. imide Sigma-Aldrich, Deisenhofen, Germany was added
wx at 10 mgrml 30 min before the addition of TNF-a 12 .
2.2. RNA preparation
Total RNA was extracted using a procedure of guani-
dinium thiocyanate lysis followed by ultracentrifugation
wx through CsCl, as described 22 . Cultured cells were washed
. 3 times with ice cold phosphate buffered saline PBS
before guanidinium thiocyanate solution was added. Tis-
sues from various adult bovine organs were homogenized
 in the same lysis buffer, using a homogenizer Ultra-tur-
. rax, Wheaton, Milleville, USA .
2.3. Construction of a subtractiÍe cDNA library
BAEC used for RNA extraction were incubated with
. q either medium alone or 1 nM TNF-a for 6 h. Poly A
RNA was obtained after two rounds of adsorption to
. wx oligo-dT-cellulose Pharmacia, Freiburg, Germany 22 .
. q For the synthesis of the first strand cDNA, 10 mg poly A
RNA from BAEC incubated with medium alone were used
 and processed by using a cDNA synthesis kit Stratagene,
. Heidelberg, Germany according to the manufacturer’s
instruction with minor modification. Briefly, a fifty-base
. oligo-d T primer-adapter with an Xho I site was used as
primer. The final reaction volume was 100 ml containing
10 mlo f1 0 = first strand buffer, 0.01 M dithiothreitol
. DTT , 0.6 mM dATPrdGTPrdTTP, 0.3 mM 5-Methyl-
dCTP, 0.56 mgrml primer, 0.2 Urml RNase inhibitor, 1.0
w 32x  ml a-P dATP specific activityf800 Cirmmol; Amer-
. . sham Buchler , and 5 ml2 0 U rml M-MuLV reverse
. transcriptase Gibco BRL, Eggenstein, Germany . After 1
h incubation at 378C, the same volume of 0.2 M NaOH
was added to the reaction and incubated at 708C for 20
min to hydrolyse the mRNA template. The labeled cDNA
 was applied to a Sephadex G-50 column Pharmacia,
. Freiburg, Germany and precipitated with ethanol. The
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integrity of the cDNA was confirmed by an alkaline gel
followed by autoradiography. Subtractive hybridization was
wx carried out according to the method of Davis et al. 23 .
. Precipitated cDNA was suspended in 50 mg1 0 ml poly
. q A RNA isolated from BAEC incubated with 1 nM
TNF-a for 6 h as described above. The hybridization
 reaction was carried out in a sealed glass capillary 50 ml;
. siliconized in 0.5 M phosphate buffer, 5 mM EDTA,
0.5% SDS, with a final volume of 12 ml. The reaction was
incubated for 20 h at 658C in a shaking water bath.
Hydroxyapatite chromatography was then used to fraction-
ate the mixture in 0.12 M phosphate buffer, 0.1% SDS.
. Single-stranded material 5.1% of labeled cDNA was
 eluted at 608C and double-stranded materials 94.9% of
. labeled cDNA at 988C. Second strand cDNA was synthe-
 sized with DNA polymerase I Klenow fragment; Strata-
. gene, Heidelberg, Germany and the hairpin loop was
 cleaved with 120 Urml nuclease S1 Stratagene, Heidel-
. wx berg, Germany at 378C for 30 min 24 . An EcoRI
. adaptor Stratagene, Heidelberg, Germany was used to
prepare the adhesive 5
X-ends. Xho I adapter-primer ends
were digested with Xho I and cDNAs above 300 bp were
selected by Sephacryl S-400 column chromatography. The
cDNA was ligated into lambda ZAP II vector arms
. Stratagene, Heidelberg, Germany with known orienta-
 tion, and the ligation mixture packaged Stratagene, Hei-
. delberg, Germany according to the manufacturers instruc-
tion.
2.4. Differential plaque hybridization
The lambda cDNA library was plated with XL1-blue
. host cells Stratagene, Heidelberg, Germany in 150 mm
diameter dishes at a density of 5,000 plaque forming units
 per dish. A duplicate set of nitrocellulose filters Amersham
. Buchler, Braunschweig, Germany was taken from each
. q dish. 1 mg poly A RNA isolated from BAEC untreated
or treated with 1 nM TNF-a for 6 h by two rounds of
 adsorption to oligo-dT-cellulose Pharmacia, Heidelberg,
. wx Germany 22 was used to synthesize cDNA probes of up
to 2=10
9 counts per minrmg specific-activity, using
 M-MuLV reverse transcriptase Gibco BRL, Eggenstein,
. w 32x  Germany and a-P dCTP specific activityf3,000
. Cirmmol; Amersham Buchler, Braunschweig, Germany .
 Prehybridization was performed in 5=SSPE 1=SSPE
contains 0.18 M NaCl, 10 mM Na PO , 1 mM EDTA, pH 34
. . 7.7 , 0.5% sodium dodecyl sulfate SDS , 5= Denhardt’s
wx  solution 22 , 0.02 mgrml salmon sperm DNA Sigma-Al-
. drich, Deisenhofen, Germany , and 50% formamide
. volrvol; Gibco BRL, Eggenstein, Deutschland at 428C
for 2 h. Filters were hybridized in the same solution for 40
h with 2=10
6 counts per minrml labeled cDNA. Wash-
 ing was performed once in 2=SSC 1=SSC is 150 mM
. NaCl, 15 mM sodium citrate , 0.1% SDS at room tempera-
ture for 15 min and then in 0.1=SSC, 0.5% SDS at 428C
for 30 min. Filters were exposed to Agfa Curix RP 1000 G
X-ray films with intensifying screen at y808C for 2 days.
Plaques preferentially hybridized with the cDNA probe of
unstimulated cells were selected. After a second round
screening, single plaques were purified.
2.5. Cross-screening to determine related cDNA sequences
For cross-hybridization analyses, lambda phage clones,
wx eluted in phage dilution buffer 22 , were transferred to
200=200 mm
2 dishes containing XL1-blue host cells
. Stratagene, Heidelberg, Germany in a grid array and
incubated at 378C for 6–8 h. The plaques were lifted with
 q positively charged nylon filters Hybond N ; Amersham
. Buchler, Braunschweig, Germany . Up to 10 filters were
obtained from each dish. The inserts of the lambda recom-
binant clones to be used as probes were subcloned into
 pBluescript SK phagemids Stratagene, Heidelberg, Ger-
. many by an in vivo excision procedure with helper phage
. R 408 Stratagene, Heidelberg, Germany . The plasmid
w 32x DNAs were a-P -labeled using a random primer label-
. w ing system Promega, Heidelberg, Germany and a-
32x  P dCTP specific activityf3,000 Cirmmol; Amersham
. Buchler, Braunschweig, Germany . The hybridization was
carried out under the same condition as described above.
Afterwards the filters were extensively washed with 0.1=
SSC, 0.5% SDS at 688C for 1 h and exposed to X-ray
films at y808C overnight.
2.6. Sequencing of TNF-a suppressed cDNAs
Double-stranded cDNAs in pBluescript SK, obtained in
wx cross-screening, were used for dideoxy sequencing 25 ,
 using modified DNA polymerase I Sequenase 2.0; Amer-
. w 35x sham Buchler, Braunschweig, Germany and a-S dATP
specific activityf1,000 Cirmmol, Amersham Buchler,
. Braunschweig, Germany . All clones selected as indepen-
dent in cross-screening were partially sequenced from both
ends, using y40 and Reverse Primers for the pBluescript
. SK vector Stratagene, Heidelberg, Germany . Searches of
the GenBank and the EMBL data bases were performed
with the BLASTN of HUSAR sequence analysis program
. package Version 4.0 . For each clone at least 200 base
pairs from both ends were used searching for similarities
to previously published genes. The full length sequence of
the C7 cDNA was obtained by automatic sequencing
. MWG-Biotech, Ebersberg, Germany and was compared
to published sequences as described above.
2.7. Dot blot analysis
Filters for dot hybridization were prepared essentially as
wx described by Kafatos et al. 26 . Linearized plasmid pBlue-
. script SK containing each cDNA insert 1 mg was dena-
tured in 0.4 M NaOH at room temperature for 30 min and
chilled on ice. The solution was then brought to 10=SSC
. ice cold and blotted onto Hybond N membrane
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. Amersham Buchler, Braunschweig, Germany , using a
 96-well manifold apparatus Bio-Rad Laboratories,
. . q Munchen, Germany . Poly A RNA was isolated from ¨
 total RNA with a mRNA purification kit Qiagen, Hilden,
. Germany and 0.5 mg were used to synthesize radioactive
labeled cDNA probes using M-MuL V reverse transcrip-
. w 32x tase Gibco BRL, Eggenstein, Germany and a-P dCTP
specific activityf3,000 Cirmmol; Amersham Buchler,
. Braunschweig, Germany . Hybridization was carried out as
described above. The filters were washed in 0.1=SSC,
0.5% SDS at 688C for 30 min and exposed to X-ray films
at y808C. The experiments have been repeated at least
twice.
2.8. Nuclear run-on transcription assay
Nuclear run-on transcription assays were performed
wx essentially as described previously 27–29 . When used,
cycloheximide was added 30 min before TNF-a to the
BAEC. In brief, about 1=10
7 nuclei were isolated from
BAEC and run-on reactions were performed in 0.7 M KCl,
50 mM MgCl , 50 mM Tris-HCl, pH 8.0, 0.25 mM DTT, 2
w 32x 1 mM EDTA in the presence of 250 mCi a-P UTP
specific activityf3,000 Cirmmol, Amersham Buchler,
. Braunschweig, Germany and incubated for 30 min at
308C. The synthesized mRNA was treated with DNAse I
. Promega, Heidelberg, Germany , afterwards with pro-
. teinase K Sigma-Aldrich, Deisenhofen, Germany and
 extracted with 0.45 mm Millipore filters type HA, Milli-
. pore, Eschborn, Germany . RNA was collected by EtOH
precipitation and 1=10
6 counts per minrml hybridization
 solution were added to dot blot filters described in differ-
. ential plaque hybridization . The experiments have been
repeated 3 times.
2.9. Northern blot analysis
12.5 mg total RNA per lane was separated on 1.1%
agarose gels containing 6.4% formaldehyde. The integrity
of RNA was checked by ethidium bromide staining of the
18 S and 28 S ribosomal RNA. After electrophoresis RNA
was transferred overnight by capillary blotting in 20=SSC
 to Hybond N nylon membrane Amersham Buchler,
. Braunschweig, Germany . Hybridization was performed
using the same conditions as described for differential
plaque hybridization and 2-3=10
6 counts per min labeled
probe per ml hybridization solution. Selected cDNAs were
 labeled with the random primer labeling system Promega,
. Heidelberg, Germany as described for cross-hybridization.
Filters were washed 15 min at room temperature in 1=
SSC, 0.1% SDS and 20 min at 688C in 0.1=SSC, 0.5%
SDS before exposure to X-ray films overnight at y808C.
The filters were stripped and rehybridized against human
glyceraldehyde-3-phosphate dehydrogenase cDNA
. GAPDH; ATCC Rockville, USA to standardize the
amount of RNA loaded. The density of autoradiographic
signals was quantitated using a GS-700 Imaging Densito-
. meter Bio-Rad, Munchen, Germany . Relative densitom- ¨
etry units were obtained, dividing the densitometry values
for the studied gene by densitometry signals of GAPDH.
2.10. In situ hybridization
Non radioactive in situ hybridization was performed as
wx described previously 30–32 . Briefly, antisense and sense
single-strand cRNAs were synthesized from the bovine C7
. cDNA fragment 1010 bp cloned into pBluescript SK, as
described in 2.5. For the in vitro transcription an RNA
. transcription kit Stratagene, Heidelberg, Germany and
 digoxygenin-labeled UTP Boehringer, Mannheim, Ger-
. many was used. The antisense and sense probes have been
characterized by agarose gel electrophoresis and Northern
blots. The antisense riboprobe recognized the correct 3.8
kb band, while the sense probe gave no signal.
Human control vessels and aortic aneurysms were di-
rectly frozen in liquid nitrogen using isopentan. The tissue
sections were fixed in 4% paraformaldehyde in PBS, pH
7.4, and acetylated for 15 min at room temperature in
freshly prepared 0.25% acetic anhydride in 0.1 M tri-
ethenolamine HCl plus 0.9% NaCl, pH 8.0, after washing
three times with PBS. Afterwards, the glass slides were
dehydrated with 10, 25, 50, 75, 95 and 100% ethanol. The
sections were prehybridized for 2 h at room temperature
with hybridization solution containing 4=SSC, 5% dex-
tran sulfate, 100 mM Dithiothreitol, 500 mgrml denatured
 salmon sperm DNA Sigma-Aldrich, Deisenhofen, Ger-
. many , 250 mgrml yeast transfer RNA Boehringer,
. wx Mannheim, Germany , 1=Denhardt’s solution 22 , and
. 50% volrvol formamide. After prehybridization, hy-
bridization solution plus 5–10 ng cRNA probe per ml
solution was applied to each section, followed by incuba-
tion in a moist chamber for 20 h at 378C. Samples were
washed 10 min in 2=SSC at 378C, 20 min in 1=SSC at
378C, 1 h in 0.5=SSC plus 50% dimethylformamide at
428C and 10 min in 0.1=SSC at 378C. For immunological
 detection the DIG nucleic acid detection kit Boehringer,
. Mannheim, Germany was used according to the manufac-
turer’s instructions. The sections were counterstained with
. Sigma Fast Red Deisenhofen, Germany and embedded
 with Kaiser’s glycerol gelatin Merck, Darmstadt, Ger-
. many .
3. Results
3.1. SubtractiÍe hybridization and cDNA library screening
for TNF-a suppressed genes
To isolate genes suppressed by a 6 h incubation of
BAEC with 1 nM TNF-a, a subtractive cDNA library was
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constructed into the lambda ZAP II vector. The first strand
. q cDNA was synthesized from poly A RNA isolated from
unstimulated endothelial cells. It was hybridized with a
. q 10-fold excess of poly A RNA obtained from BAEC
incubated with TNF-a for 6 h. After selection by hydroxy-
apatite chromatography the cDNAs coding for genes sup-
pressed in BAEC treated for 6 h with 1 nM TNF-a, was
20 times enriched. The size of the original library was
about 23,000 plaque forming units with most of the inserts
ranging from 0.5 to 2.5 kb, as determined by DNA agarose
. gel electrophoresis data not shown . The library was
amplified once.
Approximately 50000 recombinant phage plaques were
screened by differential hybridization. Initially, 600 differ-
ential signals were detected. A second screening of the
. positive plaques revealed that 398 about 67% of the
isolated phages consistently showed differential signals. To
exclude sequence-related cDNA clones, cross-hybridiza-
tion was performed by labeling the inserts of randomly
picked clones to hybridize against all other isolated phages.
Those showing cross-hybridization were considered to be
wx derived from an identical mRNA 28 . After successive
rounds of cross-hybridization, 49 clones were considered
as unique sequences. Based on the density of the signals
and the degree of suppression, 6 clones were further
analyzed.
3.2. Sequences of TNF-a suppressed genes
The isolated cDNAs were partially sequenced and at
least 200 base pairs were analyzed from each end of the
cDNA. The sequence data were screened for similarity
with previously identified genes. This led to the identifica-
 tion of three clones: connective tissue growth factor CTGF;
. .  . A1 , fibronectin A8 and the mitochondrial genome B1 .
The sequences of the clones C1, C5 and C7 did not show
apparent identity with genes published in the data bases
searched. The full length cDNA sequence of the gene C7
was obtained and the sequence data were submitted to
. GenBank accession number AF031163 . Analysis of the
1010 bp C7 sequence revealed the cloned cDNA to code
for the 3
X untranslated region of a new gene.
3.3. Time course and dose dependence of TNF-a mediated
gene suppression on mRNA leÍel
Dot hybridization was used to determine the time de-
. q pendence of gene suppression. Poly A RNA from
BAEC incubated with 1 nM TNF-a for different periods
of time was labeled by reverse transcription, and hy-
bridized to the isolated cDNAs in the vector pBluescript
SK. GAPDH and pBluescript SK served as controls. As
shown in Fig. 1A, the suppression of the analyzed genes
w 32x Fig. 1. Time course and dose response of TNF-a mediated gene suppression in cultured BAEC. a-P -labeled cDNAs from confluent BAEC treated with
. . 1 nM TNF-a for 0 to 16 h A , or BAEC treated with different concentrations of TNF-a for 16 h B were hybridized against the pBluescript SK plasmids
. containing inserts of the cDNA clones studied. The cDNA for glyceraldehyde-3-phosphate dehydrogenase GAPDH was used to standardize the
. hybridized cDNAs and the plasmid pBluescript SK vector served as background control.
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after TNF-a stimulation was significant after at least 4 h.
. The mRNA of the mitochondrial genome B1 and C5
reached a minimum level at 4 h after addition of TNF-a,
and maintained at a level that was lower than in unstimu-
. lated cells until 16 h. The suppression of fibronectin A8
and C1 was maximal at 8 h and stayed at a lower level
than in unstimulated cells until 16 h. By contrast, the
. expression of CTGF A1 was significantly suppressed
after 8 h and reached a minimum at 16 h, the longest time
point analyzed. The maximal suppression for C7 was
detected between 4 and 8 h after TNF-a addition and till
16 h the mRNA expression did not recover.
Suppression of gene expression was also dependent on
. the dose of TNF-a Fig. 1B . The effect of TNF-a was
half-maximal at about 200 pM, corresponding to the affin-
ity of the TNF-receptors. Heat inactivated TNF-a had no
effect on cultured BAEC.
3.4. Nuclear run-on transcription assay
To determine whether TNF-a downregulation of the
gene expression occurred at the transcriptional level, we
performed a nuclear run-on analysis. For this purpose, we
isolated nuclei from BAEC untreated or treated with 1 nM
TNF-a for 0.5 to 4 h. A plasmid containing cDNA for
bovine vimentin, which is not TNF-a responsive, showed
strong equivalent hybridization in all experimental groups.
. As shown in Fig. 2A, two genes CTGF; A1, and C7 were
suppressed at the transcriptional level. The transcriptional
. suppression of CTGF A1 and C7 was significant already
within 30 min after TNF-a stimulation. Afterwards the
. CTGF A1 expression was continuously downregulated to
a weak signal above background until 4 h, the longest time
point analyzed. Transcriptional suppression of these genes
. occurred also in the presence of cycloheximide Fig. 2B ,
indicating that protein synthesis was not involved. The
other genes tested in nuclear run-on analysis did not reveal
. TNF-a mediated suppression data not shown . Hence,
suppression of these transcripts does not occur at the level
of transcription.
3.5. Expression of TNF-a suppressed genes in different
adult organs
Organ specific expression of the 6 TNF-a suppressed
genes was studied by dot hybridization using cDNA probes
derived from mRNA isolated from bovine organs. Expres-
sion in these organs was compared with the expression in
. cultured BAEC, fibroblasts and SMC Fig. 3 . The gene
A1, coding for CTGF, was most abundant in endothelial
cells and also expressed in highly vascularized tissues
. liver, lung and kidney . It was almost undetectable in
. skeletal and cardiac muscles. Fibronectin A8 was more
prominently expressed in SMC, and tissues like liver, lung
and aorta than in cultured BAEC. The mitochondrial
. genome B1 was most abundant in BAEC and also highly
expressed in SMC, fibroblasts and lung. C1 was expressed
ubiquitous in all cultured cells and tissues tested, with
. Fig. 2. Genes suppressed at the transcriptional level Nuclear run-on analysis . Nuclei were isolated from untreated or 1 nM TNF-a treated BAEC at the
.  . indicated time points A . BAEC were pretreated for 30 min with cycloheximide CHX, 10 mgrml and further incubated for 2 h " addition of 1 nM
. TNF-a B . The newly transcribed mRNAs were hybridized against the pBluescript SK plasmids containing inserts of the cDNA clones studied. The
. cDNA for vimentin was used to standardize the signals and the plasmid vector vector served as background control. Only the genes suppressed at the
transcriptional level are shown in this figure.
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w 32x Fig. 3. Expression of TNF-a suppressed genes in cultured cells of the vessel wall and adult bovine organs. a-P -labeled cDNAs from cultured bovine
.  .  . aortic endothelial cells BAEC , vascular smooth muscle cells SMC , and fibroblasts Fb , as well as cDNAs derived from extracts of bovine organs were
used to hybridize against the pBluescript SK plasmids containing inserts of the cDNAs studied. The cDNA for glyceraldehyde-3-phosphate dehydrogenase
.  . GAPDH was used for standardization and the plasmid vector vector served as background control.
exception of the aorta. C5 Showed the highest expression
in kidney and was undetectable in SMC and spleen tissue.
Low amounts of C7 mRNA transcripts were detected in
cell extracts of BAEC, heart, skeletal muscle, aorta, testis
and ovary. No C7 was detected in a whole liver extract.
3.6. TNF-a mediated gene suppression in different cell
types of the Íessel wall
BAEC, SMC and fibroblasts were incubated for 16 h
with 1 nM TNF-a to compare whether there are cell type
specific responses to TNF-a with respect to the 6 genes
studied. Northern blot analysis showed suppression of all 6
.  . genes in cultured BAEC Fig. 4 . The genes CTGF A1
. and mitochondrial genome B1 were suppressed in all cell
types tested. C1 and C7 showed no significant downregula-
tion in fibroblasts and SMC, whereas these genes are
significant downregulated by TNF-a in BAEC. Fi-
. bronectin A8 was suppressed in BAEC and fibroblasts
and not detectable in SMC. C5 was downregulated in
BAEC and in fibroblasts. Therefore, the response of cul-
tured vascular cells to TNF-a is not uniform.
3.7. Expression of the C7 mRNA in ÍiÍo in human ad-
Íanced aortic aneurysms
Sections for in situ hybridization were obtained from
human control vessels and advanced aortic aneurysms.
Digoxygenin labeled antisense and sense riboprobes for a
non radioactive in situ hybridization were synthesized
from the cloned bovine full length C7 cDNA fragment. A
healthy control artery, an uninflamed and an inflamed
advanced aortic aneurysm were investigated for the expres-
sion of the C7 RNA. No C7 RNA transcripts were detected
. in healthy control arteries Fig. 5A and inflamed advanced
aortic aneurysm with high amounts of infiltrated inflamma-
. tory cells around the vessels Fig. 5C . By contrast, the
expression of the C7 RNA was strongly induced within the
endothelial cells in uninflamed advanced aortic aneurysm
. Fig. 5B . In vivo C7 transcripts were not detected in other
cells of the vessel wall than the endothelial cells, indicat-
ing a cell specific overexpression in uninflammed ad-
vanced aortic aneurysm. Within advanced aortic aneurysms
the endothelial C7 RNA expression is altered by inflamma-
tory cells, since in serial sections of a single atherosclerotic
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.  . Fig. 4. TNF-a mediated gene suppression in different cell types of the vessel wall. Bovine aortic endothelial cells BAEC, column and lane 1, 2 , fibroblasts Fb, column and lane 3, 4 and vascular smooth
.  .  . muscle cells SMC, column and lane 5, 6 were analysed by Northern blots before Control, light shading and after a 16 h incubation with 1 nM TNF-a TNF, dark shading . The Northern blot signals were
quantitated by densitometry, where GAPDH served as normalization standard. The calculated relative densitometry units are shown as bar graphs and the hybridization signals are depicted below. The size of
the mRNAs was determined based on 18 S and 28 S ribosomal RNA. The molecular weight of the band recognized by the different cDNA clones is placed in brackets next to the obtained signal.
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Fig. 5. Expression of the C7 mRNA in vivo in advanced human aortic aneurysms. Sections were obtained from frozen human control vessels and aortic
.  . aneurysms. Digoxygenin labeled antisense AS and sense S riboprobes for a non radioactive in situ hybridization were synthesized from the cloned
. bovine full length C7 cDNA fragment. The cell specific mRNA expression of C7 was investigated in a healthy control artery A , in an uninflamed aortic
. . aneurysm B , and an inflamed aortic aneurysm C . Pictures of the vessels were taken with a 200=magnification. The tissues were counter stained with
. Sigma Fast Red and positive signals are recognizable by a brown colour. C7 sense S served as negative control.
patient C7 expression decreased in areas of inflammatory
cell accumulation.
4. Discussion
Most data available about the TNF-a effect on cultured
. endothelial cells refer to the immediate 10 min to 3 h
response. In the present study we asked whether gene
 suppression is a prominent feature of the intermediate 6 to
. 16 h endothelial cell response to TNF-a. Due to the time
. point 6 h selected, we did not find any of the genes
wx known to be suppressed by TNF-a within 1 h 16–18 . For
the construction of the subtractive cDNA library the cD-
NAs were digested with Xho I to release the Xho I
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adapters before cloning into the lambda ZAP II phage
arms. Therefore, genes like thrombomodulin, the nitric
oxide synthase and the vascular endothelial cell growth
factor receptor KDRrflk-1 exposing a Xho I restriction
site could not be cloned using this strategy. We isolated 49
genes previously not described as downregulated by TNF-a
in cultured endothelial cells and further analyzed 6 of
them. This suggests that gene suppression is indeed an
important feature of the TNF-a mediated, intermediate
change in the endothelial cell phenotype. Downregulation
. of the studied genes occurred by two mechanisms: i 4
genes are only downregulated in a time and dose depen-
. dent manner in dot blots Fig. 1 , indicating posttranscrip-
. tional mechanisms and ii 2 of the 6 genes analyzed are
suppressed independent of protein synthesis at the tran-
. scriptional level Fig. 2 . Primary response genes, such as
the 2 genes suppressed at the transcriptional level, have in
other systems been shown to encode paracrine factors,
initiating a cascade of molecular events, finally resulting in
wx alterations of the cellular phenotype 12,29,33 . Future
studies will be required to learn more about the biological
properties of proteins encoded by the cDNAs with previ-
ously unpublished sequences.
Some data are available with respect to the functional
significance of gene suppression by TNF-a: One example
is the TNF-a mediated increase in vascular permeability
wx 34,35 , which is a hallmark of inflammatory reactions. In
vitro studies showed that fibronectin is decreased in the
extracellular matrix after endothelial cells have been ex-
wx . posed to TNF-a 36 . A suppression of fibronectin A8 by
TNF-a in cultured BAEC could not be detected by nuclear
run-on analysis at the transcriptional level in BAEC.
. Therefore, we conclude that fibronectin A8 downregula-
tion occurs at least in part by TNF-a mediated destabiliza-
wx tion of the mRNA 37 . Addition of fibronectin to the
culture medium prevents the TNF-a induced enhancement
wx of the monolayer permeability 36 , suggesting that TNF-a
mediated suppression of fibronectin in endothelial cells is
an important event in the cytokine mediated capillary leak
syndrome. This is further supported by the finding, that
synthetic fibronectin peptides are capable of inhibiting
infiltration of inflammatory cells in transforming growth
wx factor-b1 knock out mice 38 .
The early developing stage of arteriosclerosis is accom-
panied with high local TNF-a concentrations within the
vessel wall in foam cells. In advanced arteriosclerotic
lesions TNF-a is decreased and vascular smooth muscle
cells proliferate. The most abundant clone isolated in our
. screening is connective tissue growth factor CTGF; A1 .
. We found CTGF A1 to be expressed in endothelial cells,
fibroblasts and vascular smooth muscle cells. Furthermore,
this gene is downregulated by TNF-a in all cell types
. tested Fig. 4 . CTGF is a secreted growth factor for
wx mesenchymal cells 39,40 mediating its signal at least in
part by binding to the platelet-derived growth factor recep-
tor. CTGF was found to be expressed in high levels in
advanced arteriosclerotic lesions and therefore, it is a
potential participant in the development of arteriosclerotic
wx . lesions 41 . However, in our study we found CTGF A1
to be suppressed by TNF-a in BAEC, fibroblasts and
smooth muscle cells, indicating that TNF-a is not the only
mediator relevant for arteriosclerosis. TGF-b has recently
been shown to induce CTGF in smooth muscle cells and
wx fibroblasts 41,42 , consistent with the hypothesis that
TGF-b controlled gene expression is important in the
pathogenesis of vascular disease.
The disease activity of the cloned new gene C7 in
vascular diseases was investigated by in situ hybridization
in advanced aortic aneurysms. The C7 RNA was found to
be overexpressed exclusively in the endothelium of human
 vessels in uninflammed advanced aortic aneurysm Fig.
. . 5B and undetectable in control arteries Fig. 5A , indicat-
ing the gene potentially participating in the development of
aortic aneurysms. C7 RNA transcripts were undetectable in
endothelial cells in inflamed advanced aortic aneurysm
with large amounts of infiltrated inflammatory cells within
. the vessels Fig. 5C . Downregulation of the endothelial
cell specific gene C7 was shown in vivo in inflamed
advanced aortic aneurysm accompanied by high local
TNF-a concentrations and in vitro by TNF-a in endothe-
lial cells. Therefore, downregulation of the C7 cDNA
occurs in endothelial cells in vitro and in vivo.
C7 expression was detected in RNA extracts of the
. bovine aorta using the method of dot hybridization Fig. 3
whereas no transcripts were found within normal human
. arteries by in situ hybridization Fig. 5A . The observed
difference in the C7 expression is due to the sensitivities of
the methods used because in whole tissue extracts of
human control arteries C7 was detected by dot hybridiza-
. tion data not shown . It is possible that the bovine probe
is not sensitive enough to give above background signals
in human tissue sections expressing only low amounts of
C7 using the technique of in situ hybridization.
It remains unclear whether the C7 signal in whole
extracts of skeletal or cardiac muscle is indicative of a
strong endothelial C7 signal or other cells than endothelial
cells. The negativity of liver extracts despite the high
vascularization suggests the C7 signal in skeletal and
cardiac muscle to be derived from non vascular cells, since
the liver contains not fever endothelial cells than heart or
skeletal muscle. In addition C7 mRNA was found in
. cultured smooth muscle cells and fibroblasts Fig. 4 . Only
a careful organ survey using in situ hybridization can
clarify this point.
 Suppression of CTGF A1; resulting in decreased pro-
. liferation of fibroblasts and smooth muscle cells , suppres-
 sion of fibronectin A8; enhancing the capillary permeabil-
. ity, an important initial step in angiogenesis , and low
 expression of C7 overexpression was detected in ad-
. vanced aortic aneurysm can all be interpreted as protec-
tive for the vascular system. Our hypothesis is that cy-
tokine mediated enhanced capillary permeability, and sup-
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pression of growth factors for subendothelial cell layers
prevent hypoxia in proliferating tissue, as it occurs in
TNF-a mediated tissue remodelling. However more de-
tailed studies are required to confirm this hypothesis. The
genes isolated might provide new tools for the investiga-
tion of vascular disease. In this respect differences in the
cellular response of endothelial cells, fibroblasts and vas-
. cular smooth muscle cells Fig. 4 open additional ways
for the study of the differential TNF-a signalling in vari-
ous cells of the vascular wall.
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